| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | CC-115 |
|---|
| Description | Purity >95%. CC-115 is a potent dual inhibitor of mTOR and DNA-PK (IC50 s = 22 and 15 nM, respectively). CC-115 reduces PC3 cancer cell growth in vitro (IC50 = 138 nM) and exhibits effective reduction of murine PC3 tumor xenografts (mEC50 = 1 mg/kg). In a Phase I clinical trial, formulations containing CC-115 reduced lymph node sizes in almost all patients with chronic lymphocytic leukemia (CLL) that also have ataxia telangiectasia mutated (ATM) kinase deletions. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1-ethyl-3,4-dihydro-7-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-pyrazino[2,3-b]pyrazin-2(1H)-one |
|---|
| Gene, Accession, CAS # | CAS: 1228013-15-7 |
|---|
| Catalog # | LS-H7021 |
|---|
| Price | |
|---|
| Order / More Info | CC-115 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|